Drug firm Dr Reddy's Laboratories on Thursday said its consolidated net profit rose by 27.87 per cent to Rs 335.98 crore for the quarter ended June 30, 2012, driven by growth of generics segment in key markets including North America and Russia.
The company had posted a net profit of Rs 262.74 crore for the quarter ended June 30, 2011, Dr Reddy's Laboratories said in a statement.
Net income of the company rose to Rs 2,540.61 crore for the quarter under consideration from Rs 1,978.32 crore for the year ago period.
During the quarter the company launched 33 new generic products, filed 18 new product registrations and filed 7 Drug Master Files (DMFs) globally.
Copyright @Thomson Reuters 2012
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
